Does ENCORAFENIB Cause Platelet count decreased? 41 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Platelet count decreased have been filed in association with ENCORAFENIB (BRAFTOVI). This represents 0.5% of all adverse event reports for ENCORAFENIB.
41
Reports of Platelet count decreased with ENCORAFENIB
0.5%
of all ENCORAFENIB reports
5
Deaths
16
Hospitalizations
How Dangerous Is Platelet count decreased From ENCORAFENIB?
Of the 41 reports, 5 (12.2%) resulted in death, 16 (39.0%) required hospitalization.
Is Platelet count decreased Listed in the Official Label?
Yes, Platelet count decreased is listed as a known adverse reaction in the official FDA drug label for ENCORAFENIB.
What Other Side Effects Does ENCORAFENIB Cause?
Death (1,004)
Off label use (989)
Nausea (758)
Fatigue (685)
Diarrhoea (574)
Neoplasm progression (548)
Pyrexia (539)
Product use in unapproved indication (506)
Vomiting (429)
Rash (414)
What Other Drugs Cause Platelet count decreased?
LENALIDOMIDE (7,491)
NIRAPARIB (4,102)
ELTROMBOPAG OLAMINE (3,419)
RUXOLITINIB (3,028)
RITUXIMAB (2,404)
VENETOCLAX (2,367)
DEXAMETHASONE (2,321)
PALBOCICLIB (2,277)
CYCLOPHOSPHAMIDE (1,894)
RIBAVIRIN (1,701)
Which ENCORAFENIB Alternatives Have Lower Platelet count decreased Risk?
ENCORAFENIB vs ENDOXAN
ENCORAFENIB vs ENDOXAN BAXTER
ENCORAFENIB vs ENDOXAN INJ
ENCORAFENIB vs ENDOXAN , POUDRE POUR
ENCORAFENIB vs ENFORTUMAB VEDOTIN